Disclaimer: The following information is provided for educational and research purposes only. Cyclazodone is a research chemical that is not approved for human consumption. This is not medical advice. All research involving this compound should be conducted by qualified professionals in controlled laboratory settings.
What It Is
Cyclazodone is a centrally acting stimulant belonging to the oxazoline class, chemically related to Pemoline. It is sometimes discussed in the research community as a functional stimulant with reported wakefulness-promoting and focus-enhancing effects.
Many researchers myself included, consider it one of the closer functional analogs to amphetamine-type stimulants, particularly Adderall®, though it acts through distinct mechanisms and may have a different risk profile.
Mechanism of Action (Overview)
-
Acts primarily as a CNS stimulant, increasing alertness, focus, and motivation in animal models.
-
Believed to act on dopaminergic and noradrenergic systems, similar in part to Pemoline.
-
Reported to have a longer duration of action than many short-acting stimulants.
Preclinical data on Cyclazodone remains limited, and its safety profile is not fully established.
Theoretical Dosing Protocols Reported in the Research Community
| Type | Reported Range | Frequency | Notes |
|---|---|---|---|
| Initial exploratory | 10 mg | 1x | Often used to assess sensitivity. |
| Typical working range | 15–30 mg | 1x | Anecdotally reported as producing stimulant-like effects. |
| Max reported ceiling | 30 mg | — | Higher dosing may increase risk of liver and cardiac toxicity. |
Important:
-
Never exceed 30 mg in a single session according to anecdotal reports.
-
Use sparingly — no more than 2x per week is commonly mentioned to reduce strain on liver and cardiovascular systems.
-
Liver function monitoring is strongly advised in any research setting involving chronic use.
Key Safety & Research Considerations
-
Potential for liver enzyme elevation and cardiotoxicity at higher doses or frequent use.
-
Unknown long-term safety profile.
-
Should only be handled in controlled lab environments by trained professionals.
-
Co-administration with other stimulants or hepatotoxic compounds may increase risk.
Summary
-
Cyclazodone is a Pemoline-derived research stimulant that some consider comparable to amphetamine-type stimulants in subjective effect.
-
The most commonly reported range is 15–30 mg, with strict caution on dose frequency.
-
Due to potential hepatic and cardiac risk, it remains a high-caution compound for any research.